Author:
Kurata Takayasu,Tamura Kenji,Okamoto Isamu,Satoh Taroh,Nakagawa Kazuhiko,Fukuoka Masahiro
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference5 articles.
1. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004
2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003
3. Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy;Niyikiza;Mol Cancer Ther,2002
4. Nakagawa K, Kudoh S, Matsui K, Negoro S, Yamamoto N, Latz JE, et al. A phase I study of pemetrexed supplemented with folic acid and vitamin B12 in Japanese patients with solid tumors. Presented at the 16th EORTC-NCI-AACR, Geneva, Switzerland, September 28–October 1, 2004.
5. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment;Semb;J Clin Oncol,1998
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献